Breakthrough CAR-T Cell Therapy Shows Promise Against Deadly Pediatric Brain Tumors
This article from GEN discusses recent successes in CAR-T cell therapy against solid pediatric tumors.
Empowering Drug Hunters with High-Throughput Protein Crystallography
Watch this webinar by Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Debanu Das from Accelero Biostructure, Inc as keynote speaker.
How to Optimize Your T Cell Therapy Workflow—Without the Use of Serum or Feeder Cells
Optimize T cell therapy with serum-free solutions using GMP ImmunoCult™ and expert tips in this Q&A Report.
Relapse Prevention in Schizophrenia: Caplyta’s Clinical Trial Success
This article from Fierce Pharma discusses Intra-Cellular's recent clinical trial success with Caplyta for relapse prevention in schizophrenia.
Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)
The FGSL aims to form collaborations to advance our understanding of development and disease mechanism through functional interrogation of the genome at scale.
Unraveling Immunotherapy Resistance in Advanced Melanoma: Novel Insights from Longitudinal Spatial Multiomics Studies
Explore immunotherapy resistance in melanoma with Dr. Camelia Quek through advanced spatial multiomics and single-cell analysis insights.
Supporting the Development of Biologics Through the IND‑Enabling Studies and Clinical Phases
In this webinar, Dr. Linda Randall shares how Pharmaron’s global teams are supporting the development of biological drugs from discovery to commercial supply.
Licensing Biological Materials: Crucial Considerations for Preclinical Researchers
Licensing biological material is critical to the success of preclinical research—join us to gain insights and avoid costly pitfalls.
The ADMET Toolkit: Impact on Compound Design and Optimisation
Watch this webinar by Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Rob Riley as keynote speaker, on the ADMET Toolkit for clinical pharmacokinetics.
From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies
Join Dr. Grace Lee and Dr. Frederik Deroose as they discuss important considerations and challenges during the Investigational New Drug (IND) application process, with a focus on cell and gene therapy.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.
Challenges and Opportunities for Treatment of Metastatic Breast Cancer
Join Dr. Marsha Rosner as she explores innovative strategies and novel approaches to tackle the challenges of metastatic triple-negative breast cancer, a particularly aggressive form of cancer affecting a diverse group of women.
Illuminating Immunohistochemistry: Right-sizing Your Validation and Regulatory Strategy
Join us for the second installment of our enlightening webinar series with Precision for Medicine, focusing on optimizing immunohistochemistry validation and regulatory strategies.
A New Approach to Vector-Free CRISPR Editing Starting From Single Cells
Join us to learn how CellEDIT can be used for targeted gene editing.
BioMarin Streamlines Pipeline, Discontinues Preclinical Gene Therapy BMN 293
BioMarin has decided to discontinue its preclinical gene therapy, known as BMN 293, which aims to treat myosin-binding protein C3 (MYBPC3) hypertrophic cardiomyopathy.
Using In Vitro Assays to Model Complex Biology with PhenoVista’s Assay Services
Learn about PhenoVista’s unique service offerings and how expertise in developing complex, in vitro studies to provide actionable and relevant data can help drive drug discovery forward.
New CAR T Cell Therapy Shows Promise in Treating Aggressive Brain Cancers
Researchers at McMaster University recently discovered a signaling pathway -- known as PTP4A-ROBO1 -- that glioblastoma (GBM) cells exploit to invade the brain.
Critical Gatekeepers in Cancer Therapy and Prognosis, the Claudin Protein Family
The Claudin protein family is essential in tight junctions, regulating ion and water flow between cells and maintaining tissue integrity to prevent cancer cell migration.
Bringing Oncology Intelligence to Early Drug Development With AI-Powered Response Predictions
In this webinar, learn how AI technologies can accelerate oncology drug discovery and enhance the success of anti-cancer agents.
Applications of Human Intestinal Organoid Cultures in Drug Discovery
Discover insights from Dr. Victoria Conlin and Danny Leung on intestinal organoids and their drug screening applications.
Promising Advances in Lupus Treatment with CAR-T
Roberto Caricchio has been studying lupus for nearly three decades, observing slow progress in treatment. However, German scientists recently discovered that cellular medicines can drive lupus into remission, something that has been unable to be achieved with traditional drugs.
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Join us for an in-depth exploration of immunohistochemistry (IHC) in the first installment of our comprehensive webinar series with Precision for Medicine.
Implementing the Colony-Forming Unit (CFU) Assay As a Potency Assay for Hematopoietic Cell Therapy Products
Join our webinar to learn how to effectively implement the CFU assay as a potency assay for hematopoietic cell therapy products.
Applications of Humanized Mice in the Evaluation of Antibody-Drug Conjugates to Treat Autoimmune Diseases
Join experts from GemPharmatech and BioRay Pharmaceutical as they discuss the use of humanized mice to evaluate antibody-drug conjugates for treating autoimmune diseases.
